Table 1.
Factors that increase the risk of infection in patients with solid tumors
| Risk factor(s)a | Additional explanatory comments |
|---|---|
| Neutropenia | Chemotherapy, radiation therapy, bone marrow infiltration with tumor, drugs (e.g., ganciclovir) |
| Disruption of anatomic barriers (e.g., skin, mucosal surfaces) | Chemotherapy (mucositis), radiation therapy, vascular access catheters, urinary catheters, percutaneous endoscopic gastrostomy tubes and other medical devices, surgical/diagnostic procedures |
| Obstruction due to primary or metastatic tumor | Airways: post-obstructive pneumonia, lung abscess, empyema, fistula formation (e.g., broncho-pleural or trachea-esophogeal) |
| Biliary tract: ascending cholangitis, hepatic and pancreatic abscess | |
| Bowel: bowel obstruction, necrosis, perforation, peritonitis, hemorrhage | |
| Urinary tract: urinary tract infection, renal abscess, prostatitis or prostatic abscess | |
| Procedure and devices | Diagnostic/therapeutic surgery: surgical site infections, wound dehiscence, abscess formation |
| Shunts: disseminated infection (bacteremia) shunt-related infections such as meningitis/ventriculitis, hepato-biliary infections, complicated urinary tract infections | |
| Prosthetic devices: infected prosthesis, osteomyelitis and/or septic arthritis, local abscess formation, disseminated infection | |
| Miscellaneous factors | Age, nutritional status, prior antibiotic exposure, loss of gag reflex |
aMultiple risk factors frequently occur in the same patient